Baptist M&S Imaging was founded by the Baptist Health System and is one of the first established radiology groups in San Antonio. Our ten outpatient radiology imaging centers are conveniently located throughout San Antonio in the following areas: Downtown, Medical Center, Mission Trail, Northeast, North Central, Schertz, Westover Hills and the Baptist Breast Center is located in Stone Oak, Westover Hills and Downtown.
Baptist M&S Imaging Associates uses the latest radiology imaging center technology available and offers all modalities of radiological services including Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Digital and 3-D Mammography and High Definition Breast MRI, Ultrasound Imaging, X-Ray Services, Bone Densitometry (DXA) Exams, Nuclear Medicine and much more. We continually work hard to improve access to quality radiology imaging services by developing strong relationships with a large number of insurance and managed care providers. We specialize in accommodating patients with managed healthcare plans and accept virtually all forms of insurance, as well as Medicaid and Medicare.
Our team of 40 Board-Certified Radiologists is committed to patient and physician satisfaction. It's a concept that has served Baptist M&S Imaging Associates for more than half a century and will continue to guide us into the future. Your care is our priority, and at Baptist M&S Imaging Associates, you can count on quality service.
Click here to Contact Us for more information
Baptist M&S Imaging Offers Low Dose CT Lung Screening Program
9/1/2014 11:00:00 PM
Baptist M&S Imaging (BMSI) is offering a lung cancer screening program that follows the recommendations of the U.S. Preventive Services Task Force’s (USPSTF) Lung Cancer Screening Program. This is the first program of its kind in San Antonio, combining the diagnostic abilities of BMSI with the clinical expertise offered by a team of pulmonologists, surgeons, oncologists, and primary care physicians to offer a multidisciplinary screening program. This test utilizes low-dose computed tomography scans (LDCT) and appropriate follow-up care that significantly reduces lung cancer deaths. In December 2013, the USPSTF recommended screening of adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years.
This screening is critical because lung cancer continues to be nation’s leading cancer killer – taking the lives of more people each year than breast, colon and prostate cancers combined. The most important risk factor for lung cancer is smoking, which results in approximately 85% of all U.S. lung cancer cases. Although the prevalence of smoking has decreased, approximately 37% of U.S. adults are current or former smokers. The incidence of lung cancer increases with age and occurs most commonly in persons aged 55 years or older. Increasing age and cumulative exposure to tobacco smoke are the 2 most common risk factors for lung cancer. Lung cancer has a poor prognosis, and nearly 90% of persons with lung cancer die of the disease. However, early-stage non–small cell lung cancer (NSCLC) has a better prognosis and can be treated with surgical resection.
Although lung cancer screening is not an alternative to smoking cessation, the U.S. Preventive Services Task Force (USPSTF) has found adequate evidence that annual screening for lung cancer with LDCT in a defined population of high-risk persons can prevent a substantial number of lung cancer–related deaths. The magnitude of benefit to the person depends on that person's risk for lung cancer because those who are at highest risk are most likely to benefit. Screening cannot prevent most lung cancer–related deaths, and smoking cessation remains essential.
Smoking cessation is the most important intervention to prevent NSCLC. The advice that continues is smokers should stop smoking and nonsmokers should prevent from being exposed to tobacco smoke. This continues to be the most effective ways to decrease the morbidity and mortality associated with lung cancer. Current smokers should be informed of their continuing risk for lung cancer and offered cessation treatments. Screening with LDCT should be viewed as an adjunct to tobacco cessation interventions.
For more information about scheduling a screening for lung cancer, contact Baptist M&S Imaging at (210)228-XRAY (228-9729).
We want to hear from you. Contact Baptist M&S Imaging by phone at (210) 228-XRAY (9729).